KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Exact Sciences (EXAS) over the last 15 years, with Q4 2025 value amounting to $3.1 billion.

  • Exact Sciences' Total Non-Current Liabilities fell 249.59% to $3.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.1 billion, marking a year-over-year decrease of 249.59%. This contributed to the annual value of $3.1 billion for FY2025, which is 249.59% down from last year.
  • Latest data reveals that Exact Sciences reported Total Non-Current Liabilities of $3.1 billion as of Q4 2025, which was down 249.59% from $3.1 billion recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Total Non-Current Liabilities peaked at $3.2 billion during Q4 2024, and registered a low of $2.7 billion during Q1 2021.
  • In the last 5 years, Exact Sciences' Total Non-Current Liabilities had a median value of $2.9 billion in 2023 and averaged $2.9 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 4300.77% in 2021, then tumbled by 450.83% in 2025.
  • Exact Sciences' Total Non-Current Liabilities (Quarter) stood at $2.9 billion in 2021, then fell by 1.67% to $2.8 billion in 2022, then rose by 5.61% to $3.0 billion in 2023, then rose by 7.37% to $3.2 billion in 2024, then decreased by 2.5% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q4 2025, $3.1 billion for Q3 2025, and $3.0 billion during Q2 2025.